Efficacy of Proton Pump Inhibitors vs. H2-Receptor Antagonists in GERD  Patients: A Double-Blind RCT

Sajjad Hussain Sabir, Syed Osama Talat, Imran Ahmed Moinuddin, Maira Aslam, Nabeel  Sardar Muhammad, Atif Mahmood, Farah Naz Tahir

Efficacy of Proton Pump Inhibitors vs. H2-Receptor Antagonists in GERD Patients: A Double-Blind RCT

Authors

Sajjad Hussain Sabir, Syed Osama Talat, Imran Ahmed Moinuddin, Maira Aslam, Nabeel Sardar Muhammad, Atif Mahmood, Farah Naz Tahir

Keywords:

GERD, Proton Pump Inhibitors, H2-Receptor Antagonists

Abstract

Gastroesophageal reflux disease (GERD) is prevalent globally, necessitating effective therapeutic
strategies. This double-blind randomized controlled trial compared the efficacy and safety of
proton pump inhibitors

References

Nybacka S, et al. A low FODMAP diet plus traditional dietary advice versus a lowcarbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS): a single-centre, single-blind, randomised controlled trial. The Lancet Gastroenterology & Hepatology. 2024. (A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS): a single-centre, single-blind, randomised controlled trial - The Lancet Gastroenterology & Hepatology)

Downloads

Published

2025-05-31

How to Cite

Sajjad Hussain Sabir, Syed Osama Talat, Imran Ahmed Moinuddin, Maira Aslam, Nabeel Sardar Muhammad, Atif Mahmood, Farah Naz Tahir. (2025). Efficacy of Proton Pump Inhibitors vs. H2-Receptor Antagonists in GERD Patients: A Double-Blind RCT . International Journal of Pharmacy Research & Technology (IJPRT), 15(1), 1241–1249. Retrieved from https://ijprt.org/index.php/pub/article/view/566